FDA Claims Success with PROs as Trial Endpoints


You may have read our white paper on the new dataset: patient reported outcomes, but did you know that the FDA is now on board?

“Patient-reported outcomes are important because the value of any medical intervention ultimately lies in improving the patient’s own sense of well-being. And they have the practical advantage of measuring effects that clinicians can’t readily evaluate, such as pain.” Read more here.